Advanced Search
Your search returned 206 results
  • Oct 29, 2020
    New Technologies Address Most Common Challenges During Head and Neck Surgery

    Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the NIM Vital™ nerve monitoring...

  • Sep 30, 2020

    Avenu's Percutaneous Fistula Creation Technology Will Strengthen the Medtronic Peripheral Vascular Access Portfolio and Reinforce Medtronic's Commitment to Improving Outcomes for Patients with...

  • Aug 25, 2020
    Q1 Revenue of $6.5 Billion Decreased 13% Reported and Approximately 17% Organic

    DUBLIN, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2021, which ended July 31, 2020. The company reported...

  • Aug 11, 2020
    Acquisition Expands Medtronic Capabilities to Serve People Using Multiple Daily Injections (MDI) to Manage Diabetes

    DUBLIN and SAN DIEGO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the planned acquisition of privately-held Companion...

  • Jul 15, 2020
    Medtronic Will Become the First Company to Offer an Integrated Solution Including Artificial Intelligence-Driven Surgical Planning, Personalized Spinal Implants and Robotic Assisted Surgery

    DUBLIN and LYON, France, July 15, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), a global leader in medical technology, and Medicrea (Euronext Growth Paris: FR0004178572 – ALMED Medicrea;...

Show 5102550100 per page